Q32 Bio board chair withdraws resignation, will continue role

Q32 Bio Inc. (NASDAQ: QTTB) announced that Mark Iwicki has withdrawn his resignation from the company's board of directors, effective December 17, 2025.

Iwicki had previously notified the company of his intention to resign from the board effective December 31, 2025, citing plans to reduce the number of boards he serves on and focus on his role as chief executive officer of Inhibikase Therapeutics Inc.

The company stated that given the reduced number of boards on which Iwicki now serves, he withdrew his resignation with the full support of the board. Iwicki will continue in his roles as chair of the board and the compensation committee, as well as a member of the audit committee.

The information is based on a company statement.

You May Also Be Interested In

• RegenxBio completes dosing in RGX-202 confirmatory Duchenne study
• Canadian Solar earns SSI silver traceability cert for ingot and cell sites
• Brightstar Lottery extends Oregon Lottery contract through 2031